These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 36603580)
1. From ABCD to E for endothelin in resistant hypertension. Abraham GR; Davenport AP Cell; 2023 Jan; 186(2):240-242. PubMed ID: 36603580 [TBL] [Abstract][Full Text] [Related]
2. Endothelin System in Hypertension and Chronic Kidney Disease. Schiffrin EL; Pollock DM Hypertension; 2024 Apr; 81(4):691-701. PubMed ID: 38059359 [TBL] [Abstract][Full Text] [Related]
4. Potential Role of Endothelin in Early Vascular Aging. Trindade M; Oigman W; Fritsch Neves M Curr Hypertens Rev; 2017; 13(1):33-40. PubMed ID: 28413991 [TBL] [Abstract][Full Text] [Related]
5. Is endothelin targeting finally ready for prime time? Schinzari F; Tesauro M; Cardillo C Clin Sci (Lond); 2024 Jun; 138(11):635-644. PubMed ID: 38785409 [TBL] [Abstract][Full Text] [Related]
6. Aprocitentan and the endothelin system in resistant hypertension. Clozel M Can J Physiol Pharmacol; 2022 Jul; 100(7):573-583. PubMed ID: 35245103 [TBL] [Abstract][Full Text] [Related]
7. Endothelins and venous tone in DOCA-salt hypertension. van den Meiracker AH J Hypertens; 2002 Apr; 20(4):587-9. PubMed ID: 11910286 [No Abstract] [Full Text] [Related]
8. Role of endothelin in the control of peripheral vascular tone in human hypertension. Taddei S; Virdis A; Ghiadoni L; Sudano I; Magagna A; Salvetti A Heart Fail Rev; 2001 Dec; 6(4):277-85. PubMed ID: 11447302 [TBL] [Abstract][Full Text] [Related]
9. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders. Goddard J; Webb DJ Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541 [TBL] [Abstract][Full Text] [Related]
10. The clinical potential of endothelin receptor antagonists in cardiovascular medicine. Ferro CJ; Webb DJ Drugs; 1996 Jan; 51(1):12-27. PubMed ID: 8741230 [TBL] [Abstract][Full Text] [Related]
11. Endothelin in hypertension: a role for receptor antagonists? Moreau P Cardiovasc Res; 1998 Sep; 39(3):534-42. PubMed ID: 9861294 [TBL] [Abstract][Full Text] [Related]
14. [Role of endothelin in arterial hypertension. From agonists to antagonists]. Moreau P Presse Med; 1997 May 3-10; 26(15):700-2. PubMed ID: 9183367 [TBL] [Abstract][Full Text] [Related]
15. Update on Endothelin Receptor Antagonists in Hypertension. Burnier M Curr Hypertens Rep; 2018 May; 20(6):51. PubMed ID: 29779164 [TBL] [Abstract][Full Text] [Related]
16. Clinical experience with endothelin antagonists. Webb DJ; Strachan FE Am J Hypertens; 1998 Apr; 11(4 Pt 3):71S-79S. PubMed ID: 9607370 [TBL] [Abstract][Full Text] [Related]
17. Endothelin: role in hypertension. Schiffrin EL Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507 [TBL] [Abstract][Full Text] [Related]
18. Potential role of endothelin-1 and endothelin antagonists in cardiovascular diseases. Schmitz-Spanke S; Schipke JD Basic Res Cardiol; 2000 Aug; 95(4):290-8. PubMed ID: 11005584 [TBL] [Abstract][Full Text] [Related]
19. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Cardillo C; Kilcoyne CM; Cannon RO; Panza JA Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270 [TBL] [Abstract][Full Text] [Related]
20. [Endothelin receptor antagonists--a brief description of the new class of drugs]. Kowalczyk A; Kołodziejczyk M; Gorąca A Postepy Hig Med Dosw (Online); 2014 Jan; 68():1076-80. PubMed ID: 25228516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]